Acadia Healthcare (NASDAQ:ACHC) (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.
Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs. Its comprehensive services address disorders such as depression, anxiety, bipolar disorder, substance use disorders and eating disorders. In addition to evidence-based therapy and medication management, the company offers specialized programs in brain stimulation therapies, telepsychiatry and dual-diagnosis care to support holistic patient outcomes.
With more than 280 facilities spanning over 35 states and Puerto Rico, Acadia has also extended its footprint internationally through the acquisition of a majority stake in the Priory Group in the United Kingdom. This geographic presence allows the company to adapt its clinical protocols to local regulatory frameworks while maintaining centralized quality standards and operational consistency.
Led by President and Chief Executive Officer William F. McAndrew Jr., Acadia Healthcare continues to pursue growth opportunities that enhance its care continuum, expand digital health capabilities and strengthen partnerships with healthcare systems, payors and community organizations. The company’s strategic focus remains on delivering high-quality, evidence-based behavioral health services to meet evolving patient needs.
